4.7 Article

Cancer and Inflammation: Differentiation by USPIO-Enhanced MR Imaging

Related references

Note: Only part of the references are listed.
Article Radiology, Nuclear Medicine & Medical Imaging

Comparison of Two Different Iron Oxide-Based Contrast Agents for Discrimination of Benign and Malignant Lymph Nodes

Sonja Kinner et al.

INVESTIGATIVE RADIOLOGY (2012)

Article Radiology, Nuclear Medicine & Medical Imaging

Axillary lymph node metastases in patients with breast carcinomas: Assessment with nonenhanced versus USPIO-enhanced MR imaging

Mazda Memarsadeghi et al.

RADIOLOGY (2006)

Article Radiology, Nuclear Medicine & Medical Imaging

Ferumoxtran-10-enhanced MR lymphangiography: Does contrast-enhanced imaging alone suffice for accurate lymph node characterization?

MG Harisinghani et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2006)

Article Radiology, Nuclear Medicine & Medical Imaging

Urinary bladder cancer: Preoperative nodal staging with ferumoxtran-10-enhanced MR imaging

WMLLG Deserno et al.

RADIOLOGY (2004)

Article Radiology, Nuclear Medicine & Medical Imaging

Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro

S Metz et al.

EUROPEAN RADIOLOGY (2004)

Article Radiology, Nuclear Medicine & Medical Imaging

Axillary lymph node metastases:: A statistical analysis of various parameters in MRI with USPIO

C Stets et al.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2002)

Article Radiology, Nuclear Medicine & Medical Imaging

Superparamagnetic iron oxide - Enhanced MR imaging of head and neck lymph nodes

MG Mack et al.

RADIOLOGY (2002)